DNA
Ginkgo Bioworks·NYSE
--
--(--)
--
--(--)
5.04 / 10
Netural
Fund flow is strong (7.87/10) with modest overall inflow (~0.49) but negative trend, except large investors showing positive flow. Sentiment remains neutral. Analyst coverage is limited, delivering a unanimous Strong Sell rating, reinforcing a bearish outlook.
Fund Flow Rating
Analyst RatingStrong Sell
Wall Street Opinions
Strong Sell
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
100%
Date2026-03-12
InstitutionBTIG
Times predicted2
Historical Win Rate100.0%
What is the analyst consensus for DNA?
- DNA holds a Bearish analyst rating, with 100% of experts assigning a Strong Sell grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.04/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
